CCND1 and pulmonary arterial hypertension: Importantly, delivery of a cell permeable peptide containing CSD reversed pulmonary hypertension and the accompanying increases in pulmonary phospho-STAT3, cyclin D1, and cyclin D3 expression in rats exposed to monocrotaline [83].